Your browser doesn't support javascript.
loading
Feasibility, acceptability, and preliminary efficacy of yoga to improve maternal mental health and immune function during the COVID-19 crisis (Yoga-M2 trial): a pilot randomized controlled trial.
Shidhaye, Rahul; Bangal, Vidyadhar; Bhargav, Hemant; Tilekar, Swanand; Thanage, Chitra; Gore, Suryabhan; Doifode, Akshada; Thete, Unnati; Game, Kalpesh; Hake, Vaishali; Kunkulol, Rahul.
Afiliación
  • Shidhaye R; Department of Psychiatry, Pravara Institute of Medical Sciences, Loni, India.
  • Bangal V; Department of Health, Ethics, and Society, Care and Public Health Research Institute, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, Netherlands.
  • Bhargav H; Department of Obstetrics and Gynecology, Pravara Institute of Medical Sciences, Loni, India.
  • Tilekar S; Department of Integrative Medicine, National Institute of Mental Health and Neurosciences, Bengaluru, India.
  • Thanage C; School of Public Health and Social Medicine, Pravara Institute of Medical Sciences, Loni, India.
  • Gore S; Directorate of Research, Pravara Institute of Medical Sciences, Loni, India.
  • Doifode A; Directorate of Research, Pravara Institute of Medical Sciences, Loni, India.
  • Thete U; Directorate of Research, Pravara Institute of Medical Sciences, Loni, India.
  • Game K; Directorate of Research, Pravara Institute of Medical Sciences, Loni, India.
  • Hake V; Directorate of Research, Pravara Institute of Medical Sciences, Loni, India.
  • Kunkulol R; Department of Obstetrics and Gynecology, Pravara Institute of Medical Sciences, Loni, India.
Front Hum Neurosci ; 17: 1115699, 2023.
Article en En | MEDLINE | ID: mdl-37200951
ABSTRACT

Introduction:

Women are vulnerable during pregnancy as they experience multiple physical and psychological problems which can lead to stress and poor quality of life ultimately affecting the development of the fetus and their health during and after pregnancy. Prior evidence suggests that prenatal yoga can improve maternal health and well-being and can have a beneficial effect on immune system functioning. To date, no study has been conducted in a rural, low-resource setting in India to assess the feasibility, acceptability, and preliminary efficacy of a yoga-based intervention on perceived stress, quality of life, pro-inflammatory biomarkers, and symptoms of upper respiratory tract infections.

Methods:

To address this gap and assess whether a yoga-based intervention could improve maternal mental health and immunity during the COVID-19 crisis (Yoga-M2 trial), a single-blind individual randomized parallel group-controlled pilot trial with a 11 allocation ratio was implemented. We randomly allocated 51 adult pregnant women, with gestational age between 12-24 weeks in the Yoga-M2 arm (n = 25) or the enhanced usual care arm (EUC) (n = 26). Feasibility and acceptability were assessed using the process data and In-Depth Interviews (IDIs) with the trial participants and yoga instructors. Multiple linear regression was used to compare follow-up scores for quantitative outcomes.

Results:

A three-month follow-up assessment was completed for 48 out of 51 participants (94.12%). We did not find any statistically significant difference between both arms in total Perceived Stress Scale scores, quality of life (Eq-5D-5L index), and serum C Reactive Protein levels at the three-month follow-up assessment. The critical barriers to practicing yoga were lack of knowledge about the benefits of yoga, lack of 'felt need' to practice yoga, lack of time to practice, lack of space, lack of transport, and lack of peer group to practice yoga. Despite this, women who regularly practiced yoga described the benefits and factors which motivated them to practice regularly.

Discussion:

The learnings from this trial will help design the explanatory trial in the future and the study findings can also be used by the primary health care system to deliver yoga-based interventions in the newly created health and wellness centers. Trial registration This trial was prospectively registered with the Clinical Trials Registry of India on 25 January 2022. https//www.ctri.nic.in/Clinicaltrials/showallp.php?mid1=65173&EncHid=&userName=CTRI/2022/01/039701. Trial registration number CTRI/2022/01/039701.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Qualitative_research Idioma: En Revista: Front Hum Neurosci Año: 2023 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Qualitative_research Idioma: En Revista: Front Hum Neurosci Año: 2023 Tipo del documento: Article País de afiliación: India